Tech Company Financing Transactions
Sientra Funding Round
On 3/29/2012, Sientra announced $65 million in Series C investment from Abingworth, Clarus and OrbiMed.
Transaction Overview
Company Name
Announced On
3/29/2012
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series C
Investors
Proceeds Purpose
The new funds bolster Sientra's treasury and will support full commercialization of its recently FDA-approved portfolio of Silicone Breast Implants, as well as fund general operations and provide working capital.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
420 S. Fairview Ave. 200
Santa Barbara, CA 93117
USA
Santa Barbara, CA 93117
USA
Phone
Website
Email Address
Overview
Sientra (NASDAQ: SIEN) is developing medical devices focused on the plastic surgery and aesthetics markets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Nugent
Chief Financial Officer
Paul Little
Chief Operating Officer
Charlie Huiner
Controller
Valerie Miller
VP - Customer Service
Deborah Bettencourt
VP - Operations
Rosalyn D'Incelli
VP - Product Management
Daniel Carlisle
VP - Regulatory Affairs
JoAnn Kuhne
VP - Sales
Jason O'Hearn
Browse more venture capital transactions:
Prev: 3/29/2012: Semprius venture capital transaction
Next: 3/29/2012: Symphony Commerce venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs